$317 Million is the total value of Aviva Holdings Ltd.'s 10 reported holdings in Q4 2018. The portfolio turnover from Q3 2018 to Q4 2018 was 0.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
MRTX | MIRATI THERAPEUTICS INC | $133,028,000 | -9.9% | 3,135,966 | 0.0% | 41.94% | +6.4% | |
INSG | Buy | INSEEGO CORP | $78,017,000 | +124.0% | 18,799,229 | +107.8% | 24.60% | +164.7% |
MDCO | MEDICINES CO | $72,325,000 | -36.0% | 3,778,742 | 0.0% | 22.80% | -24.4% | |
ESPR | Sell | ESPERION THERAPEUTICS INC NE | $21,374,000 | -59.9% | 464,649 | -61.3% | 6.74% | -52.6% |
INSEEGO CORPnote 5.500% 6/1 | $12,097,000 | +7.8% | 13,700,000 | 0.0% | 3.81% | +27.4% | ||
SLDB | SOLID BIOSCIENCES INC. | $308,000 | -43.2% | 11,488 | 0.0% | 0.10% | -33.1% | |
MGNX | Sell | MACROGENICS INC. | $48,000 | -99.7% | 3,815 | -99.4% | 0.02% | -99.6% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
- Braslyn Ltd. #1
- Avid Ltd. #2
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-02-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
MIRATI THERAPEUTICS INC | 32 | Q3 2023 | 100.0% |
INSEEGO CORP | 21 | Q3 2023 | 39.6% |
INSEEGO CORP | 14 | Q3 2023 | 10.2% |
PAMPA ENERGIA SA ADR | 12 | Q3 2022 | 26.0% |
MEDICINES CO | 11 | Q3 2019 | 87.4% |
ESPERION THERAPEUTICS INC NE | 9 | Q1 2019 | 14.2% |
TANGO THERAPEUTICS INC. | 9 | Q3 2023 | 0.2% |
SOLID BIOSCIENCES INC. | 9 | Q2 2020 | 0.1% |
INSEEGO CORP | 8 | Q1 2020 | 41.4% |
MACROGENICS INC. | 6 | Q4 2018 | 10.0% |
View Aviva Holdings Ltd.'s complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-14 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-15 |
13F-HR | 2022-05-16 |
13F-HR | 2022-02-14 |
13F-HR | 2021-11-15 |
View Aviva Holdings Ltd.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.